Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wael El-Rifai

Showing results (121-130 of 159) with videos related to

Pageof 16
Sort By:
Gastroenterology|June 16, 2010
Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cellsJinxiong Wei, Toni A Nagy, Anna Vilgelm, et al.
Gastroenterology|September 3, 2013
Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasiaAhmed Katsha, Mohammed Soutto, Vikas Sehdev, et al.
Redox Biology|June 13, 2026
Acidic bile salts induce APE1-dependent PRDX2 activation to drive oxaliplatin resistance via ferroptosis inhibitionLei Chen, Farah Ballout, Zheng Chen, et al.
The Journal of Clinical Investigation|April 15, 2011
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humansMohammed Soutto, Abbes Belkhiri, M Blanca Piazuelo, et al.
Signal Transduction and Targeted Therapy|January 13, 2021
Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapyAjaz A Bhat, Parvaiz Yousuf, Nissar A Wani, et al.
Signal Transduction and Targeted Therapy|February 27, 2021
Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapyAjaz A Bhat, Parvaiz Yousuf, Nissar A Wani, et al.
Molecular Therapy Oncolytics|September 21, 2023
Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinomaMd Obaidul Islam, Krishnapriya Thangaretnam, Heng Lu, et al.
Investigational New Drugs|September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 8, 2025
CDK1 drives SOX9-mediated chemotherapeutic resistance in gastric cancerMarwah Al-Mathkour, Zheng Chen, Julio Poveda, et al.
Investigational New Drugs|October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Pageof 16

Showing results (121-130 of 159) with videos related to

Sort By:
Pageof 16
Gastroenterology|June 16, 2010
Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cellsJinxiong Wei, Toni A Nagy, Anna Vilgelm, et al.
Gastroenterology|September 3, 2013
Aurora kinase A promotes inflammation and tumorigenesis in mice and human gastric neoplasiaAhmed Katsha, Mohammed Soutto, Vikas Sehdev, et al.
Redox Biology|June 13, 2026
Acidic bile salts induce APE1-dependent PRDX2 activation to drive oxaliplatin resistance via ferroptosis inhibitionLei Chen, Farah Ballout, Zheng Chen, et al.
The Journal of Clinical Investigation|April 15, 2011
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humansMohammed Soutto, Abbes Belkhiri, M Blanca Piazuelo, et al.
Signal Transduction and Targeted Therapy|January 13, 2021
Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapyAjaz A Bhat, Parvaiz Yousuf, Nissar A Wani, et al.
Signal Transduction and Targeted Therapy|February 27, 2021
Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapyAjaz A Bhat, Parvaiz Yousuf, Nissar A Wani, et al.
Molecular Therapy Oncolytics|September 21, 2023
Smoking induces WEE1 expression to promote docetaxel resistance in esophageal adenocarcinomaMd Obaidul Islam, Krishnapriya Thangaretnam, Heng Lu, et al.
Investigational New Drugs|September 8, 2018
Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 8, 2025
CDK1 drives SOX9-mediated chemotherapeutic resistance in gastric cancerMarwah Al-Mathkour, Zheng Chen, Julio Poveda, et al.
Investigational New Drugs|October 19, 2018
Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancerLaura W Goff, Nilofer S Azad, Stacey Stein, et al.
Pageof 16